# PreQual Product: Afluria® - IIV3 - SMART Product Dataset for Prequalified Vaccines v0.2.0

* [**Table of Contents**](toc.md)
* [**Indices**](indices.md)
* [**Artifact Index**](artifacts.md)
* **PreQual Product: Afluria® - IIV3**

## Example Binary: PreQual Product: Afluria® - IIV3

This content is an example of the [WHO Vaccine PreQual DB - Finished Vaccine Products](StructureDefinition-FinishedVaccineProducts.md) Logical Model and is not a FHIR Resource

```

{
  "resourceType": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/FinishedVaccineProducts",
  "productType": "FinishedVaccineProduct",
  "dateOfPrequal": "2020-02-07",
  "assessmentProcedure": "PrequalificationAbridged",
  "status": "Prequalified",
  "pharmaceuticalForm": "LiquidReadytouse",
  "presentation": {
    "coding": [
      {
        "system": "https://extranet.who.int/prequal/vaccines/prequalified-vaccines",
        "code": "Vial",
        "display": "Vial"
      }
    ]
  },
  "numDoses": 10,
  "productId": {
    "system": "https://extranet.who.int/prequal/api",
    "value": "a3K3X000006Mik2UAC"
  },
  "productName": "FVP-P-367",
  "vaccineFullName": "Influenza vaccine trivalent (split virion, inactivated)",
  "vaccineAbbreviatedName": "IIV3",
  "vaccineCommercialName": "Afluria®",
  "vaccineTypeId": {
    "system": "https://extranet.who.int/prequal/api",
    "value": "a3S3X000003cSpMUAU"
  },
  "routeOfAdministration": "Intramuscular",
  "vialMonitor": "Type 2",
  "multidoseVialPolicy": "WHO recommends that opened vials of this vaccine may be used in subsequent immunization sessions (up to 28 days) if the conditions outlined in the WHO Policy Statement are met.",
  "applicantId": {
    "system": "https://extranet.who.int/prequal/api",
    "value": "0013X0000498p4PQAQ"
  },
  "applicantName": "Seqirus Australia Pty Ltd",
  "nraId": {
    "system": "https://extranet.who.int/prequal/api",
    "value": "0013X0000498p6CQAQ"
  },
  "nraName": "US Food and Drug Administration- Office of Vaccine Research and Review (US FDA)",
  "nraCountry": "United States of America",
  "shelfLife": "15 months",
  "storageTemperature": "2 - 8°C",
  "lastPublishingDate": "2024-09-10",
  "publishingRemarks": "The shelf-life of Afluria TIV MDV is 15 months at 2°C to 8°C.Pallet shipper contains 119 shipping boxes of 952 vials (95200 doses of 0.5 mL or 190400 doses of 0.25 mL)",
  "preservative": "Thiomersal",
  "preservativeConcentration": "0.01%w/v",
  "manufacturerReference": {
    "reference": "Organization/Manufacturer0013X0000498p4PQAQ"
  },
  "responsibleNRAReference": {
    "reference": "Organization/Holder0013X0000498p6CQAQ"
  },
  "manufacturerLM": {
    "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualManufacturer/PreQualManufacturer0013X0000498p4PQAQ"
  },
  "nraLM": {
    "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualNRA/PreQualNRA0013X0000498p6CQAQ"
  },
  "vaccineLM": {
    "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualVaccine/PreQualVaccinea3S3X000003cSpMUAU"
  },
  "packagingLM": [
    {
      "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualProductPackaging/PreQualPackaginga3H3X000001VafWUAS"
    }
  ],
  "documentLM": [
    {
      "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualDocumentDetail/PreQualDocument069NN000005l2N0YAI"
    }
  ],
  "siteLM": [
    {
      "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualSiteDetail/PreQualSite0013X0000498p4PQAQ"
    }
  ],
  "ingredientLM": [
    {
      "reference": "http://smart.who.int/pcmt-vaxprequal/StructureDefinition/PreQualProductIngredient/PreQualIngredienta3K3X000006Mik2UACIng4"
    }
  ]
}

```



## Resource Binary Content

application/fhir+json:

```
{snip}
```
